July e-Newsletter | Athletes & Blood Clots

Think you are too fit for a blood clot? Think again. Blood clots can happen to even the most active and physically fit people, including professional athletes and fitness enthusiasts alike. We at NBCA regularly hear from athletes who have experienced DVT and PE, even at the peak of physical fitness. The one thing that…

4th Annual Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference

The 2017 Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference, hosted by StopAfib.org, takes place this year, August 4-6, in Dallas, Texas. The conference will provide important information about the management of Afib, and bring patients and leading experts in the field together for a unique opportunity to engage and learn about living your best life…

Betrixaban: New Oral Blood Thinner Cleared by FDA

The U.S. Food and Drug Administration has granted Portola Pharmaceuticals permission to market a a new oral anticoagulant or “blood thinner”called betrixaban (BevyxXa®). The medication is indicated for use for the prevention of venous thromboembolism and pulmonary embolism in acutely ill patients who are not undergoing surgery, but are at risk for venous thromboembolism due…

June e-Newsletter | NBCA Summer News & Information

Summer is upon us and the time for hitting the road for the beach, family vacations, and other potentially far-off destinations is finally here. As the summer travel season kicks into high gear, don’t forget your Passport to Safety to make sure that you take steps to prevent blood clots as you soak up the…

Clinical Trial: Cancer and Blood Clots

Cancer patients can be at much higher risk for blood clots.  The National Blood Clot Alliance is pleased to be participating in THE CANVAS TRIAL, a nationwide study that is seeking to compare the benefits, harms, and burdens of two different approaches to blood clot treatment in cancer patients. THE CANVAS TRIAL is supported through…

May e-Newsletter | Celebrate National Women’s Health Week

This May, our e-Newsletter is packed with exciting information. In recognition of Women’s Health Week 2017, the National Blood Clot Alliance is partnering with the Alexandra L. Rowan Memorial Foundation to provide women with essential information about birth control and blood clot risks, and to encourage them to visit Women & Blood Clots. At this website,…

National Women’s Health Week 2017

A Movement to Raise Awareness about Birth Control and Blood Clot Risks Stand with the National Blood Clot Alliance (NBCA) during National Women’s Health Week (NWHW), May 14-20, 2017, as we share life-saving information about dangerous blood clots. Women face a distinctive risk for blood clots that spans much of their lifetime. This risk is connected…

New Study Enrolling Patients

Researchers are seeking to enroll patients in a new clinical study. The PEPPER trial is investigating which blood thinner is best for patients to use after total hip and knee replacement surgery to prevent blood clots. Researchers are currently looking to enroll 25,000 patients across 25 sites in North America. The National Blood Clot Alliance…

New Caregiver Resource Available Online

The National Blood Clot Alliance (NBCA) has partnered with ProPatient.com, a provider of interactive online patient education tools, to make available an online resource dedicated to the specific information needs of the individuals who provide care and support to people affected by venous thromboembolism. Specifically, this program is designed to empower caregivers to take an…